Word

RETROVIRAL PHARMACEUTICALS

Status

Pending

Status Code

661

Status Date

Wednesday, April 10, 2024

Serial Number

97872878

Mark Type

4

Filing Date

Tuesday, April 4, 2023

Trademark Owner History

Retroviral Therapeutics LLC

Classifications

5 Vaccines; Biological preparations for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Medical preparations for the treatment of diseases, disorders and illnesses, namely, infectious diseases, cancer, osteporosis, kidney diseases, liver diseases, viral infections, and for use in oncology and retroviruses; Pharmaceutical preparations for the treatment and prevention of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic pharmaceutical for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic vaccines

42 Bacteriological research and analysis; Bacteriological research and testing; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials involving viruses used for clinical and treatment purposes; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific and technological services, namely, design, engineering, research, development and testing in the field of immunopharmaceuticals and vaccines involving viruses used for clinical and treatment purposes

"PHARMACEUTICALS"

Trademark Events

Apr 7, 2023

New Application Entered

Apr 10, 2024

Correspondence Received In Law Office

Apr 10, 2024

Teas/Email Correspondence Entered

Apr 10, 2024

Teas Response To Office Action Received

Jan 10, 2024

Notification Of Non-Final Action E-Mailed

Apr 27, 2023

New Application Office Supplied Data Entered

Dec 29, 2023

Assigned To Examiner

Jan 10, 2024

Non-Final Action Written

Jan 10, 2024

Non-Final Action E-Mailed